---
title: "TELO.US (TELO.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TELO.US/news.md"
symbol: "TELO.US"
name: "TELO.US"
parent: "https://longbridge.com/en/quote/TELO.US.md"
datetime: "2026-05-21T18:23:51.340Z"
locales:
  - [en](https://longbridge.com/en/quote/TELO.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TELO.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TELO.US/news.md)
---

# TELO.US (TELO.US) — Related News

### [Telomir Reports Peer-Reviewed Preclinical Telomir-Zn Data Showing Dose-Dependent Survival & Reduced Hepatic Copper](https://longbridge.com/en/news/287061178.md)
*2026-05-20T12:03:01.000Z*
> Telomir reported peer-reviewed preclinical data indicating that Telomir-Zn improves survival and reduces hepatic copper 

### [Telomir Pharmaceuticals | 10-Q: FY2026 Q1 Revenue: USD 0](https://longbridge.com/en/news/286456110.md)
*2026-05-14T19:12:57.000Z*
### [Telomir Pharmaceuticals, Inc. 1Q 2026: Revenue $0 EPS $(0.03) — 10-Q Summary](https://longbridge.com/en/news/286456184.md)
*2026-05-14T19:11:01.000Z*
> Telomir Pharmaceuticals, Inc. reported a net loss of $(990,947) with no revenue for Q1 2026, an improvement from a $(2,1

### [EXCLUSIVE: Telomir Pharmaceuticals Secures FDA Nod For Its Breast Cancer Therapy To Advance Into Human Study](https://longbridge.com/en/news/284764711.md)
*2026-04-30T11:46:08.000Z*
> Telomir Pharmaceuticals has received FDA clearance for its Investigational New Drug application for Telomir-Zn, allowing

### [Teva Signals Confidence With $700 Million Pipeline Push, Buyback Plan](https://longbridge.com/en/news/284620858.md)
*2026-04-29T17:52:33.000Z*
> Teva Pharmaceuticals plans to acquire Emalex Biosciences for $700 million, enhancing its late-stage pipeline. The deal, 

### [Telomir Pharmaceuticals Completes Acquisition of TELI Pharmaceuticals, Securing Global Rights to Telomir-1 (Telomir-Zn)](https://longbridge.com/en/news/284010046.md)
*2026-04-24T13:00:00.000Z*
> Telomir Pharmaceuticals has completed the acquisition of TELI Pharmaceuticals, securing global rights to its lead progra

### [Weekly Buzz: SPRY Gains FDA Nod; EU Expands Kerendia Label; LLY Acquires CNTA; BIIB Snaps Up APLS](https://longbridge.com/en/news/281622312.md)
*2026-04-03T09:12:27.000Z*
> This week's biotech news highlights significant regulatory approvals, acquisitions, and clinical trial outcomes. ARS Pha